Location: New York, NY
CIK: 0001633313 · Show all filings
Period: Q2 2024 (← Previous) (Next →)
Filing Date: Aug 14, 2024
Total Value: $7.508B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| UTHR | UNITED THERAPEUTICS CORP | 2,858,888 | $911M | 12.1% | $134.94 | +96.1% | Common | 91307C102 |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 2,055,555 | $576M | 7.7% | $138.83 | +71.5% | Common | 558868105 |
| ASND | ASCENDIS PHARMA | 4,196,661 | $572M | 7.6% | $122.74 | — | Sponsored ADR | 04351P101 |
| ARGX | ARGENX SE | 1,238,467 | $533M | 7.1% | $186.36 | — | Sponsored ADR | 04016X101 |
| SRPT | SAREPTA THERAPEUTICS INC | 3,000,000 | $474M | 6.3% | $106.42 | +20.7% | Common | 803607100 |
| KRYS | KRYSTAL BIOTECH INC | 2,433,000 | $447M | 6.0% | $77.73 | +116.0% | Common | 501147102 |
| APLS | APELLIS PHARMACEUTICALS INC. | 11,111,111 | $426M | 5.7% | $48.71 | -7.0% | Common | 03753U106 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 4,557,416 | $375M | 5.0% | $85.96 | -3.1% | Common | 09061G101 |
| — | CEREVEL THERAPEUTICS HLDNG | 7,539,547 | $308M | 4.1% | $39.80 | — | Common | 15678U128 |
| XBI | SPDR SERIES TRUST - S&P BIOTECH | 3,035,000 | $281M | 3.7% | $89.29 | — | ETF | 78464A870 |
| FOLD | AMICUS THERAPEUTICS INC. | 27,400,000 | $272M | 3.6% | $10.47 | -1.9% | Common | 03152W109 |
| RNAM | AVIDITY BIOSCIENCES INC | 6,505,000 | $266M | 3.5% | $19.27 | +48.9% | Common | 05370A108 |
| ARWR | ARROWHEAD PHARMACEUTICALS INC. | 8,888,888 | $231M | 3.1% | $31.44 | -21.8% | Common | 04280A100 |
| XENE | XENON PHARMACEUTICALS INC | 5,666,666 | $221M | 2.9% | $18.87 | +111.9% | Common | 98420N105 |
| — | INTRA-CELLULAR THERAPIES INC | 3,000,000 | $205M | 2.7% | $70.90 | — | Common | 46116X101 |
| VERA | VERA THERAPEUTICS INC | 4,309,590 | $156M | 2.1% | $35.64 | +11.3% | Common | 92337R101 |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 2,770,000 | $122M | 1.6% | $35.93 | +17.9% | CLASS A ORD | 61559X104 |
| KYMR | KYMERA THERAPEUTICS INC | 3,888,888 | $116M | 1.5% | $31.88 | +8.6% | Common | 501575104 |
| ALNY | ALNYLAM PHARMCEUTICALS INC. | 400,000 | $97.2M | 1.3% | $155.90 | +1.3% | Common | 02043Q107 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 11,700,000 | $93.83M | 1.2% | $14.36 | -25.4% | Common | 462260100 |
| SLNO | SOLENO THERAPEUTICS INC | 2,091,666 | $85.34M | 1.1% | $38.30 | +10.7% | Common | 834203309 |
| — | MERUS N V | 1,355,000 | $80.18M | 1.1% | $37.11 | — | Common | N5749R100 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 3,888,437 | $79.83M | 1.1% | $18.81 | +11.3% | Common | 87164F105 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 12,570,000 | $77.68M | 1.0% | $10.72 | -48.5% | Common | 09058V103 |
| KURA | KURA ONCOLOGY INC | 3,541,505 | $72.92M | 1.0% | $22.49 | -8.6% | Common | 50127T109 |
| OCUL | OCULAR THERAPEUTIX INC | 8,060,000 | $55.13M | 0.7% | $6.99 | -11.7% | Common | 67576A100 |
| MNKD | MANNKIND CORP | 8,759,524 | $45.72M | 0.6% | $3.56 | +27.6% | Common | 56400P706 |
| PCVX | VAXCYTE INC | 575,000 | $43.42M | 0.6% | $69.25 | -1.7% | Common | 92243G108 |
| SYRE | SPYRE THERAPEUTICS INC | 1,839,138 | $43.24M | 0.6% | $13.77 | +144.9% | Common | 00773J202 |
| AUTL | AUTOLUS THERAPEUTICS PLC | 12,345,678 | $42.96M | 0.6% | $6.38 | — | Sponsored ADR | 05280R100 |
| TSHA | TAYSHA GENE THERAPIES INC | 18,650,000 | $41.78M | 0.6% | $2.04 | +42.9% | Common | 877619106 |
| RARE | ULTRAGENYX PHARMACEUTICAL INC | 830,000 | $34.11M | 0.5% | $49.13 | -13.1% | Common | 90400D108 |
| — | VERRICA PHARMACEUTICALS INC | 3,999,999 | $29.16M | 0.4% | $6.66 | — | Common | 92511W108 |
| — | TOURMALINE BIO INC | 2,222,222 | $28.58M | 0.4% | $24.18 | — | Common | 89157D105 |
| CGON | CG ONCOLOGY INC | 700,000 | $22.1M | 0.3% | $40.84 | -15.1% | Common | 156944100 |
| GLUE | MONTE ROSA THERAPEUTICS INC | 4,535,000 | $16.96M | 0.2% | $17.04 | -70.1% | Common | 61225M102 |
| BCYC | BICYCLE THERAPEUTICS PLC | 700,000 | $14.17M | 0.2% | $20.24 | — | Sponsored ADR | 088786108 |
| WHWK | AADI BIOSCIENCES INC | 2,849,402 | $4.16M | 0.1% | $24.27 | -92.4% | Common | 00032Q104 |
| DYN | DYNE THERAPEUTICS INC. | 115,751 | $4.085M | 0.1% | $29.06 | 0.0% | Common | 26818M108 |
| — | ADVERUM BIOTECHNOLOGIES INC | 416,666 | $2.858M | 0.0% | $14.14 | — | Common | 00773U207 |
| NGNE | NEUROGENE INC | 22,029 | $802K | 0.0% | $35.27 | 0.0% | Common | 64135M105 |